SCHEMBL486852

SCHEMBL486852

CCCCOB(O)OCCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
ANPEP P15144 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
ALDH1A1 P00352 2/20 0.40
ATM Q13315 1/20 0.37
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
LMNA P02545 1/20 0.33
PCSK9 Q8NBP7 1/20 0.33
ESR1 P03372 1/20 0.32
LTA4H P09960 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
NR5A1 Q13285 1/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28921 1.00 TSHR (0.42) TSHRANPEPADRB2ADRB1ADRB3
Ammonia Solution, Strong SCHEMBL9422473 0.97 TSHR (0.40) TSHRANPEPADRB2ADRB1ADRB3
SCHEMBL28920 0.97 TSHR (0.40) TSHRANPEPADRB2ADRB1ADRB3
SCHEMBL4190026 0.92 THRB (0.43) TSHRALDH1A1CA1CA2LMNA
SCHEMBL28122270 0.92 TSHR (0.42) TSHRANPEPADRB2ADRB1ADRB3
SCHEMBL17333189 0.92 CA12 (0.41) TSHRANPEPCA1CA2MEN1
SCHEMBL17333144 0.90 TSHR (0.52) TSHRANPEPADRB2ADRB1ADRB3
SCHEMBL28121 0.89 THRB (0.44) TSHRALDH1A1CA1CA2LMNA
SCHEMBL10632891 0.89 THRB (0.44) TSHRALDH1A1CA1CA2LMNA
SCHEMBL3648395 0.89 THRB (0.44) TSHRALDH1A1CA1CA2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852013-A Preparation method of ponatinib and intermediate thereof 武汉人福创新药物研发中心有限公司 2024-10-29 CN claimed
CN-115975416-B Reflective temperature-regulating wall coating and preparation method thereof 湖南漆雕氏制造股份有限公司 2024-01-30 CN claimed
CN-117373333-A Intraoral simulation maxillary sinus mucosa dissection experimental device and method 深圳市人民医院 2024-01-09 CN claimed
CN-116000287-A Glass-coated copper powder, copper paste, copper electrode and preparation method thereof 华东理工大学 2023-04-25 CN claimed
CN-115894884-A Trifunctional organic catalyst, and preparation method and application thereof 浙江大学 2023-04-04 CN claimed
CN-115594780-A Preparation method of borate initiator and borate initiator 西安航天动力试验技术研究所(CN) 2023-01-13 CN claimed
CN-114874826-A Calcium sulfonate-based composite grease for high-temperature long-life low-noise bearing and preparation method thereof 宝鸡文理学院 2022-08-09 CN claimed
EP-4317370-B1 LUBRICANT COMPOSITION IDEMITSU KOSAN CO (JP) 2026-05-06 EP disclosed
US-12577492-B2 Succinimide dispersants post-treated with aromatic glycidyl ethers that exhibit good soot handling performance CHEVRON ORONITE COMPANY LLC (US) 2026-03-17 US disclosed
US-20260049258-A1 LOW VISCOSITY LUBRICATING OIL CHEVRON JAPAN LTD (JP) 2026-02-19 US disclosed
US-20260035634-A1 LUBRICATING OIL COMPOSITION FOR CORROSION CONTROL CHEVRON ORONITE CO (US) 2026-02-05 US disclosed
EP-4680704-A1 AFTERTREATMENT SYSTEM FRIENDLY ENGINE OIL FORMULATION Chevron Oronite Company LLC (US) 2026-01-21 EP disclosed
EP-4680703-A1 AFTERTREATMENT SYSTEM FRIENDLY ENGINE OIL FORMULATION Chevron Oronite Company LLC (US) 2026-01-21 EP disclosed
WO-1999066009-A2 FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE ORR WILLIAM C (US) 1999-12-23 WO disclosed
EP-0954558-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR, William C. (US) 1999-11-10 EP disclosed
WO-1998026028-A1 FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY ORR WILLIAM C (US) 1998-06-18 WO disclosed
US-5512198-A WEAR RESISTANCE NIPPON OIL CO., LTD. (JP) 1996-04-30 US disclosed
EP-0582451-A1 Refrigerator oil composition for fluoroalkane refrigerant NIPPON OIL CO. LTD. (JP) 1994-02-09 EP disclosed
US-5126063-A Extreme temperature lubricants MOBIL OIL CORPORATION (US) 1992-06-30 US disclosed
US-4257958-A INORGANIC BORON-OXYGEN COMPOUND ADDITIVES TEXACO INC. (US) 1981-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035634-A1 LUBRICATING OIL COMPOSITION FOR CORROSION CONTROL NFKBIA, IKBKB, TH TSHR 3878/4885ANPEP 4756/4885ADRB2 1162/4885
US-20260049258-A1 LOW VISCOSITY LUBRICATING OIL COG3, STARD3, MB TSHR 2685/4885ANPEP 4881/4885ADRB2 2791/4885
US-12577492-B2 Succinimide dispersants post-treated with aromatic glycidyl ethers that exhibit good soot handling performance SMS, SRM, SHMT1 TSHR 2764/4885ANPEP 4684/4885ADRB2 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.